Rare diseases
Investigational molecules
Locations
Study of early versus late risankizumab treatment to evaluate immune cell response in patients with moderate to severe psoriasis
SpainStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
AustriaStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
BelgiumStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
BulgariaStudy of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial
GermanyStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
AustriaStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
BulgariaStudy of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden
FranceStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
AustriaTesting SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
BelgiumStudy of tasimelteon compared to placebo for treating insomnia in children
GermanyStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
